Clinical Trial Update: A Study Comparing the Efficacy and Safety Between H-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing H-CHOP versus R-CHOP in untreated CD20-positive diffuse large B-cell lymphoma; status and full results not yet available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• H-CHOP
• R-CHOP

Snippet

Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: Recruiting | Phase 3 | Status: UNKNOWN